The Insight Partners published latest research report on “Molecular Diagnostics Market Growth Report, Size, Share, Trends and Demand Forecast to 2028 - COVID-19 Impact and Global Analysis By Disease Area; Technology; Product and Services; End User and Geography”
The Insight Partners published latest research report on “Molecular Diagnostics Market Growth Report, Size, Share, Trends and Demand Forecast to 2028 - COVID-19 Impact and Global Analysis By Disease Area; Technology; Product and Services; End User and Geography”, the global market size is projected to grow from USD 16,258.97 million in 2021 to USD 36,176.65 million by 2028; it is expected to grow at a CAGR of 12.1% during 2021-2028.
Request Sample PDF Brochure: https://www.theinsightpartners.com/sample/TIPRE00003124
Molecular diagnostics is considered among the most reliable method to identify and analyze a microorganism. Molecular diagnostics helps in better testing, quick identification of the organism’s strain and drug susceptibility. Technological advancements, like a polymerase chain reaction (PCR), and others, the rising application of molecular diagnostics is expected to drive the market during the forecast period.
Prominent players in the molecular diagnostics market are focusing on organic strategies such as product launches, product approvals, and geographic and manufacturing expansions. These strategies help them strengthen their market positions, along with allowing them to broaden their geographic footprints. Additionally, various companies are undertaking acquisitions to garner their significance and remain competitive in the market. A few of the vital developments in the molecular diagnostics market are mentioned below:
2021- Siemens Healthineers inaugurates manufacturing facility for molecular diagnostic kits in Gujarat
The World Health Organization (WHO) stated that about 70% of deaths in low- and middle-income countries were caused by cancer in September 2021. In addition, as per the Global Burden of Disease Study in the Global Health Data Exchange and the World Health Statistics 2020 Cardiovascular Disease (CVD) mortality in China 322 per 100,000 population, India has reported 185 per 100,000 population at an early stage of CVD
Directly Purchase Premium Copy of Molecular Diagnostics Market Growth Report (2021-2028) at: https://www.theinsightpartners.com/buy/TIPRE00003124
Global Molecular Diagnostics Market Share Report, Segmentations, Regional & Country Scope:
| Report Coverage | Details |
| Market Size Value in | USD 16,258.97 million in 2021 |
| Market Size Value by | USD 36,176.65 million by 2028 |
| Growth rate | CAGR of 12.1% from 2021 to 2028 |
| Forecast Period | 2021-2028 |
| Base Year | 2021 |
| No. of Pages | 253 |
| No. of Tables | 168 |
| No. of Charts & Figures | 94 |
| Historical data available | Yes |
| Segments covered | Disease Area, Technology, Product and Services, End User and Geography |
| Regional scope | North America; Europe; Asia Pacific; Latin America; MEA |
| Country scope | US, UK, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina |
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Companies Covered | Abbott, Agilent Technologies, Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., TBG Diagnostics Limited, QIAGEN, bioMérieux SA, Siemens Healthineers AG, Illumina, Inc., Danaher, Novartis AG |
| Key Research Capabilities | Global Market Assessment, Business Development Strategies, Competitive Landscape, Opportunity Analysis, Regional and Country Level Market Analysis, Market Entry Strategies, Market Dynamics, Risk and Return Assessments, Pricing Analysis, Market Size and Forecasting, Company Profiling, Value Chain Analysis, Expansion Strategies, SWOT Analysis, New Product Development |
Browse key market insights spread across 253 pages with 168 list of tables & 94 list of figures from the report, “Molecular Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Disease Area (Oncology, Infectious diseases, Genetic testing, Cardiac diseases, Immune system disorders, and Others); Technology (Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), DNA Sequencing and Next-Generation Sequencing (NGS), In Situ Hybridization, DNA Microarray, and Others); Product and Services (Assays and Kits, Instruments, Services and Software); End User (Hospitals and Clinics, Diagnostic Laboratories, Research and Academic Institutes, and Others) and Geography)” in detail along with the table of contents: https://www.theinsightpartners.com/reports/molecular-diagnostics-market
The report highlights trends, drivers, and deterrents pertaining to market growth. The market growth is mainly attributed to an increase in demand for point-of-care devices, developments by market players, and a rise in the prevalence of associated diseases. However, the increasing prevalence of associated diseases is expected to limits market growth.
Based on disease area, the molecular diagnostics market is segmented into oncology, infectious disease, genetic testing, cardiac diseases, immune system disorders, and others. The infectious disease segment would hold the largest share of the market in 2021. The oncology segment is expected to register the highest CAGR during the forecast period. In terms of technology, the molecular diagnostics market is segmented into polymerase chain reaction, isothermal nucleic acid amplification technology, DNA sequencing and next-generation sequencing, in-situ hybridization, DNA microarray, and others. The polymerase chain reaction segment would hold the largest market share in 2021, and it is further expected to register the highest CAGR in the market during 2021–2028. Based on product and services, the molecular diagnostics market is segmented into assays and kits, instruments, and services and software. The assays and kits segment would hold the largest market share in 2021, and it is further expected to register the highest CAGR in the market during 2021–2028. In terms of end user, the molecular diagnostics market is segmented into hospitals and clinics, diagnostic laboratories, research and academic institutes, and others. The diagnostic laboratories segment would hold the largest market share in 2021, and it is further expected to register the highest CAGR in the market during 2021–2028.
The Food Safety and Inspection Service, Food and Drug Administration, and European Medical Association are a few of the major secondary sources referred to while preparing the report on the global molecular diagnostics market.
Go through further research published by The Insight Partners: (Purchase with 10% Instant Discount):
Molecular Modelling Market Forecast to 2028 - Covid-19 Impact and Global Analysis
Small Molecule Drug Discovery Market Forecast to 2027 - COVID-19 Impact and Global Analysis
Molecular Quality Controls Market Forecast to 2028 - COVID-19 Impact and Global Analysis
Molecular Biology Enzymes, Kits, and Reagents Market Forecast to 2028 - COVID-19 Impact and Global Analysis
Molecular Biology Analyzers Market Forecast to 2028 - COVID-19 Impact and Global Analysis
Molecular Cytogenetics Market Forecast to 2028 - COVID-19 Impact and Global Analysis
Low Molecular Weight Heparin Market Forecast to 2028 - COVID-19 Impact and Global Analysis
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
Press Release: https://www.theinsightpartners.com/pr/molecular-diagnostics-market/